Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex

In the fight against malaria, the key is early treatment with antimalarial chemotherapy, such as artemisinin-based combination treatments (ACTs). However, Plasmodium has acquired multidrug resistance, including the emergence of P. falciparum strains with resistance to ACT. The development of novel a...

Full description

Bibliographic Details
Main Authors: Camila Martins Gomes Morais, Ramayana Morais de Medeiros Brito, Aleksandra Weselucha-Birczyńska, Valeska Santana de Sena Pereira, Jordam William Pereira-Silva, Alexandre Menezes, Felipe Arley Costa Pessoa, Martyna Kucharska, Malwina Birczyńska-Zych, Claudia María Ríos-Velásquez, Valter Ferreira de Andrade-Neto
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.1047269/full
_version_ 1798014478103609344
author Camila Martins Gomes Morais
Camila Martins Gomes Morais
Ramayana Morais de Medeiros Brito
Ramayana Morais de Medeiros Brito
Aleksandra Weselucha-Birczyńska
Valeska Santana de Sena Pereira
Valeska Santana de Sena Pereira
Jordam William Pereira-Silva
Jordam William Pereira-Silva
Alexandre Menezes
Felipe Arley Costa Pessoa
Martyna Kucharska
Malwina Birczyńska-Zych
Malwina Birczyńska-Zych
Claudia María Ríos-Velásquez
Valter Ferreira de Andrade-Neto
author_facet Camila Martins Gomes Morais
Camila Martins Gomes Morais
Ramayana Morais de Medeiros Brito
Ramayana Morais de Medeiros Brito
Aleksandra Weselucha-Birczyńska
Valeska Santana de Sena Pereira
Valeska Santana de Sena Pereira
Jordam William Pereira-Silva
Jordam William Pereira-Silva
Alexandre Menezes
Felipe Arley Costa Pessoa
Martyna Kucharska
Malwina Birczyńska-Zych
Malwina Birczyńska-Zych
Claudia María Ríos-Velásquez
Valter Ferreira de Andrade-Neto
author_sort Camila Martins Gomes Morais
collection DOAJ
description In the fight against malaria, the key is early treatment with antimalarial chemotherapy, such as artemisinin-based combination treatments (ACTs). However, Plasmodium has acquired multidrug resistance, including the emergence of P. falciparum strains with resistance to ACT. The development of novel antimalarial molecules, that are capable of interfering in the asexual and sexual blood stages, is important to slow down the transmission in endemic areas. In this work, we studied the ability of the mettalo copper-cinchonine complex to interfere in the sexual and asexual stages of Plasmodium. The tested compound in the in vitro assay was a cinchonine derivative, named CinCu (Bis[Cinchoninium Tetrachlorocuprate(II)]trihydrate). Its biological functions were assessed by antiplasmodial activity in vitro against chloroquine-resistant P. falciparum W2 strain. The mice model of P. berghei ANKA infection was used to analyze the antimalarial activity of CinCu and chloroquine and their acute toxicity. The oocyst formation-blocking assay was performed by experimental infection of Anopheles aquasalis with P. vivax infected blood, which was treated with different concentrations of CinCu, cinchonine, and primaquine. We found that CinCu was able to suppress as high as 81.58% of parasitemia in vitro, being considered a molecule with high antiplasmodial activity and low toxicity. The in vivo analysis showed that CinCu suppressed parasitemia at 34% up to 87.19%, being a partially active molecule against the blood-stage forms of P. berghei ANKA, without inducing severe clinical signs in the treated groups. The transmission-blocking assay revealed that both cinchonine and primaquine were able to reduce the infection intensity of P. vivax in A. aquasalis, leading to a decrease in the number of oocysts recovered from the mosquitoes’ midgut. Regarding the effect of CinCu, the copper-complex was not able to induce inhibition of P. vivax infection; however, it was able to induce an important reduction in the intensity of oocyst formation by about 2.4 times. It is plausible that the metallo-compound also be able to interfere with the differentiation of parasite stages and/or ookinete-secreted chitinase into the peritrophic matrix of mosquitoes, promoting a reduction in the number of oocysts formed. Taken together, the results suggest that this compound is promising as a prototype for the development of new antimalarial drugs. Furthermore, our study can draw a new pathway for repositioning already-known antimalarial drugs by editing their chemical structure to improve the antimalarial activity against the asexual and sexual stages of the parasite.
first_indexed 2024-04-11T15:18:00Z
format Article
id doaj.art-359a2dcb89994e6093216f0aed5cad7e
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-11T15:18:00Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-359a2dcb89994e6093216f0aed5cad7e2022-12-22T04:16:26ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882022-12-011210.3389/fcimb.2022.10472691047269Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complexCamila Martins Gomes Morais0Camila Martins Gomes Morais1Ramayana Morais de Medeiros Brito2Ramayana Morais de Medeiros Brito3Aleksandra Weselucha-Birczyńska4Valeska Santana de Sena Pereira5Valeska Santana de Sena Pereira6Jordam William Pereira-Silva7Jordam William Pereira-Silva8Alexandre Menezes9Felipe Arley Costa Pessoa10Martyna Kucharska11Malwina Birczyńska-Zych12Malwina Birczyńska-Zych13Claudia María Ríos-Velásquez14Valter Ferreira de Andrade-Neto15Laboratory of Malaria and Toxoplasmosis Biology, Department of Microbiology and Parasitology, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, BrazilPost-Graduate Program in Parasitic Biology, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, BrazilLaboratory of Malaria and Toxoplasmosis Biology, Department of Microbiology and Parasitology, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, BrazilLaboratory of Immunology and Genomics of Parasites, Department of Parasitology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, BrazilDepartment of Chemical Physics, Faculty of Chemistry, Jagiellonian University, Kraków, PolandLaboratory of Malaria and Toxoplasmosis Biology, Department of Microbiology and Parasitology, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, BrazilPost-Graduate Program in Biochemistry and Molecular Biology, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, BrazilLaboratory of Infectious Disease Ecology in the Amazon, Leônidas and Maria Deane Institute, Fiocruz, Manaus, AM, BrazilPost-Graduate Program in Living Conditions and Health Situations in the Amazon, Leônidas and Maria Deane Institute, Fiocruz, Manaus, AM, BrazilPost-Graduate Program in Biology of Host-Pathogen interaction, Leônidas and Maria Deane Institute, Fiocruz, Manaus, AM, BrazilLaboratory of Infectious Disease Ecology in the Amazon, Leônidas and Maria Deane Institute, Fiocruz, Manaus, AM, BrazilDepartment of Chemical Physics, Faculty of Chemistry, Jagiellonian University, Kraków, PolandDepartment of Infectious and Tropical Diseases, Medical College, Jagiellonian University, Kraków, Poland0Department of Infectious Diseases, The University Hospital in Kraków, Kraków, PolandLaboratory of Infectious Disease Ecology in the Amazon, Leônidas and Maria Deane Institute, Fiocruz, Manaus, AM, BrazilLaboratory of Malaria and Toxoplasmosis Biology, Department of Microbiology and Parasitology, Biosciences Center, Federal University of Rio Grande do Norte, Natal, RN, BrazilIn the fight against malaria, the key is early treatment with antimalarial chemotherapy, such as artemisinin-based combination treatments (ACTs). However, Plasmodium has acquired multidrug resistance, including the emergence of P. falciparum strains with resistance to ACT. The development of novel antimalarial molecules, that are capable of interfering in the asexual and sexual blood stages, is important to slow down the transmission in endemic areas. In this work, we studied the ability of the mettalo copper-cinchonine complex to interfere in the sexual and asexual stages of Plasmodium. The tested compound in the in vitro assay was a cinchonine derivative, named CinCu (Bis[Cinchoninium Tetrachlorocuprate(II)]trihydrate). Its biological functions were assessed by antiplasmodial activity in vitro against chloroquine-resistant P. falciparum W2 strain. The mice model of P. berghei ANKA infection was used to analyze the antimalarial activity of CinCu and chloroquine and their acute toxicity. The oocyst formation-blocking assay was performed by experimental infection of Anopheles aquasalis with P. vivax infected blood, which was treated with different concentrations of CinCu, cinchonine, and primaquine. We found that CinCu was able to suppress as high as 81.58% of parasitemia in vitro, being considered a molecule with high antiplasmodial activity and low toxicity. The in vivo analysis showed that CinCu suppressed parasitemia at 34% up to 87.19%, being a partially active molecule against the blood-stage forms of P. berghei ANKA, without inducing severe clinical signs in the treated groups. The transmission-blocking assay revealed that both cinchonine and primaquine were able to reduce the infection intensity of P. vivax in A. aquasalis, leading to a decrease in the number of oocysts recovered from the mosquitoes’ midgut. Regarding the effect of CinCu, the copper-complex was not able to induce inhibition of P. vivax infection; however, it was able to induce an important reduction in the intensity of oocyst formation by about 2.4 times. It is plausible that the metallo-compound also be able to interfere with the differentiation of parasite stages and/or ookinete-secreted chitinase into the peritrophic matrix of mosquitoes, promoting a reduction in the number of oocysts formed. Taken together, the results suggest that this compound is promising as a prototype for the development of new antimalarial drugs. Furthermore, our study can draw a new pathway for repositioning already-known antimalarial drugs by editing their chemical structure to improve the antimalarial activity against the asexual and sexual stages of the parasite.https://www.frontiersin.org/articles/10.3389/fcimb.2022.1047269/fullPlasmodiummalaria treatmentcinchoninemettalo copper complexesantimalarial drugs
spellingShingle Camila Martins Gomes Morais
Camila Martins Gomes Morais
Ramayana Morais de Medeiros Brito
Ramayana Morais de Medeiros Brito
Aleksandra Weselucha-Birczyńska
Valeska Santana de Sena Pereira
Valeska Santana de Sena Pereira
Jordam William Pereira-Silva
Jordam William Pereira-Silva
Alexandre Menezes
Felipe Arley Costa Pessoa
Martyna Kucharska
Malwina Birczyńska-Zych
Malwina Birczyńska-Zych
Claudia María Ríos-Velásquez
Valter Ferreira de Andrade-Neto
Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex
Frontiers in Cellular and Infection Microbiology
Plasmodium
malaria treatment
cinchonine
mettalo copper complexes
antimalarial drugs
title Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex
title_full Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex
title_fullStr Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex
title_full_unstemmed Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex
title_short Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex
title_sort blood stage antiplasmodial activity and oocyst formation blockage of metallo copper cinchonine complex
topic Plasmodium
malaria treatment
cinchonine
mettalo copper complexes
antimalarial drugs
url https://www.frontiersin.org/articles/10.3389/fcimb.2022.1047269/full
work_keys_str_mv AT camilamartinsgomesmorais bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT camilamartinsgomesmorais bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT ramayanamoraisdemedeirosbrito bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT ramayanamoraisdemedeirosbrito bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT aleksandraweseluchabirczynska bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT valeskasantanadesenapereira bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT valeskasantanadesenapereira bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT jordamwilliampereirasilva bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT jordamwilliampereirasilva bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT alexandremenezes bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT felipearleycostapessoa bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT martynakucharska bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT malwinabirczynskazych bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT malwinabirczynskazych bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT claudiamariariosvelasquez bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex
AT valterferreiradeandradeneto bloodstageantiplasmodialactivityandoocystformationblockageofmetallocoppercinchoninecomplex